Ruxolitinib in combination with DNA methyltransferase inhibitors: Clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts

Ali Tabarroki; Yogen Saunthararajah; Valeria Visconte; Tracy Cinalli; Kristin Colaluca; Heesun J. Rogers; Mikkael A. Sekeres; Hien K. Duong; Brady L. Stein; Ramon V. Tiu

doi:10.3109/10428194.2014.916805

Ruxolitinib in combination with DNA methyltransferase inhibitors: Clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts

Ali Tabarroki, Yogen Saunthararajah, Valeria Visconte, Tracy Cinalli, Kristin Colaluca, Heesun J. Rogers, Mikkael A. Sekeres, Hien K. Duong, Brady L. Stein^*, Ramon V. Tiu

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Letter › peer-review

14 Scopus citations

Original language	English (US)
Pages (from-to)	497-499
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	56
Issue number	2
DOIs	https://doi.org/10.3109/10428194.2014.916805
State	Published - Feb 1 2015

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3109/10428194.2014.916805

Cite this

Tabarroki, A., Saunthararajah, Y., Visconte, V., Cinalli, T., Colaluca, K., Rogers, H. J., Sekeres, M. A., Duong, H. K., Stein, B. L., & Tiu, R. V. (2015). Ruxolitinib in combination with DNA methyltransferase inhibitors: Clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts. Leukemia and Lymphoma, 56(2), 497-499. https://doi.org/10.3109/10428194.2014.916805

@article{0afa7bba0c7547af86e1735926e4f2d2,

title = "Ruxolitinib in combination with DNA methyltransferase inhibitors: Clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts",

author = "Ali Tabarroki and Yogen Saunthararajah and Valeria Visconte and Tracy Cinalli and Kristin Colaluca and Rogers, {Heesun J.} and Sekeres, {Mikkael A.} and Duong, {Hien K.} and Stein, {Brady L.} and Tiu, {Ramon V.}",

year = "2015",

month = feb,

day = "1",

doi = "10.3109/10428194.2014.916805",

language = "English (US)",

volume = "56",

pages = "497--499",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "2",

}

Tabarroki, A, Saunthararajah, Y, Visconte, V, Cinalli, T, Colaluca, K, Rogers, HJ, Sekeres, MA, Duong, HK, Stein, BL & Tiu, RV 2015, 'Ruxolitinib in combination with DNA methyltransferase inhibitors: Clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts', Leukemia and Lymphoma, vol. 56, no. 2, pp. 497-499. https://doi.org/10.3109/10428194.2014.916805

Ruxolitinib in combination with DNA methyltransferase inhibitors: Clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts. / Tabarroki, Ali; Saunthararajah, Yogen; Visconte, Valeria et al.
In: Leukemia and Lymphoma, Vol. 56, No. 2, 01.02.2015, p. 497-499.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Ruxolitinib in combination with DNA methyltransferase inhibitors

T2 - Clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts

AU - Tabarroki, Ali

AU - Saunthararajah, Yogen

AU - Visconte, Valeria

AU - Cinalli, Tracy

AU - Colaluca, Kristin

AU - Rogers, Heesun J.

AU - Sekeres, Mikkael A.

AU - Duong, Hien K.

AU - Stein, Brady L.

AU - Tiu, Ramon V.

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84923855168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923855168&partnerID=8YFLogxK

U2 - 10.3109/10428194.2014.916805

DO - 10.3109/10428194.2014.916805

M3 - Letter

C2 - 24766471

AN - SCOPUS:84923855168

SN - 1042-8194

VL - 56

SP - 497

EP - 499

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 2

ER -

Ruxolitinib in combination with DNA methyltransferase inhibitors: Clinical responses in patients with symptomatic myelofibrosis with cytopenias and elevated blast(s) counts

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this